Trialect

Active

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator

Centers for Disease Control and Prevention

NOTE: This is a Forecasted Opportunity.

Alzheimer's disease, the most common form of dementia, is a progressive disease that begins with mild memory loss and may lead to the inability to carry on conversations and respond to one’s environment. The prevalence of Alzheimer's disease is rising with the aging of the U.S. population. In 2021, Alzheimer’s disease was the fifth leading cause of death for people aged 65 years or older in the U.S., as well as the seventh leading cause of death overall. Death rates continue to rise. The CDC Alzheimer's Disease Program, through the National Healthy Brain Initiative (HBI) and its funded partners (CDC-RFA-DP20-2003, CDC-RFA-DP20-2005, CDC-RFA-DP23-0010, and CDC-RFA-PW24-0080), provides data and information to promote brain health, address cognitive impairment, and meet the needs of caregivers through systemic and policy-driven action.

This funding opportunity aligns with actions described in the Healthy Brain Initiative Road Map series, including the State and Local Road Map for Public Health: 2023–2027 and the Road Map for Indian Country. This opportunity will fund selected organizations to build the evidence base and translate research into practice that will be adopted and used across the nation. This includes helping state, tribal, local, and territorial (STLT) public health agencies — including BOLD public health programs —to implement the Road Map Series and fulfill the aim of the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (P.L. 115-406).

Estimated Post Date:

Jan 06, 2025

Estimated Application Due Date:

Mar 07, 2025